Literature DB >> 19452503

Aberrant trafficking of human melanocortin 1 receptor variants associated with red hair and skin cancer: Steady-state retention of mutant forms in the proximal golgi.

Berta L Sánchez-Laorden1, Cecilia Herraiz, Julio C Valencia, Vincent J Hearing, Celia Jiménez-Cervantes, José C García-Borrón.   

Abstract

The melanocortin 1 receptor (MC1R), a Gs protein-coupled receptor (GPCR) expressed in melanocytes, is a major determinant of skin pigmentation and phototype. MC1R activation stimulates melanogenesis and increases the ratio of black, strongly photoprotective eumelanins to reddish, poorly photoprotective pheomelanins. Several MC1R alleles are associated with red hair, fair skin, increased sensitivity to ultraviolet radiation (the RHC phenotype) and increased skin cancer risk. Three highly penetrant RHC variants, R151C, R160W, and D294H are loss-of-function MC1R mutants with altered cell surface expression. In this study, we show that forward trafficking was normal for D294H. Conversely, export traffic was impaired for R151C, which accumulated in the endoplasmic reticulum (ER), and for R160W, which was enriched in the cis-Golgi. This is the first report of steady-state retention in a post-ER secretory compartment of a GPCR mutant found in the human population. Residues R151 and R160 are located in the MC1R second intracellular loop (il2). Two other mutations in il2, T157A preventing T157 phosphorylation and R162P disrupting a (160)RARR(163) motif, also caused intracellular retention. Moreover, T157 was phosphorylated in wild-type MC1R and a T157D mutation mimicking constitutive phosphorylation allowed normal traffic, and rescued the retention phenotype of R160W and R162P. Therefore, MC1R export is likely regulated by T157 phosphorylation and the (160)RARR(163) arginine-based motif functions as an ER retrieval signal. These elements are conserved in mammalian MC1Rs and in all five types of human melanocortin receptors. Thus, members of this GPCR subfamily might share common mechanisms for regulation of plasma membrane expression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19452503      PMCID: PMC2705480          DOI: 10.1002/jcp.21804

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  63 in total

1.  Membrane trafficking: coat control by curvature.

Authors:  Jennifer Lippincott-Schwartz; Wei Liu
Journal:  Nature       Date:  2003-12-04       Impact factor: 49.962

Review 2.  ER export: call 14-3-3.

Authors:  Oliver Nufer; Hans-Peter Hauri
Journal:  Curr Biol       Date:  2003-05-13       Impact factor: 10.834

3.  Interactive effects of MC1R and OCA2 on melanoma risk phenotypes.

Authors:  David L Duffy; Neil F Box; Wei Chen; James S Palmer; Grant W Montgomery; Michael R James; Nicholas K Hayward; Nicholas G Martin; Richard A Sturm
Journal:  Hum Mol Genet       Date:  2004-01-06       Impact factor: 6.150

Review 4.  A trip to the ER: coping with stress.

Authors:  D Thomas Rutkowski; Randal J Kaufman
Journal:  Trends Cell Biol       Date:  2004-01       Impact factor: 20.808

5.  Loss-of-function variants of the human melanocortin-1 receptor gene in melanoma cells define structural determinants of receptor function.

Authors:  Jesús Sánchez Más; Concepción Olivares Sánchez; Ghanem Ghanem; John Haycock; José Antonio Lozano Teruel; José Carlos García-Borrón; Celia Jiménez-Cervantes
Journal:  Eur J Biochem       Date:  2002-12

6.  Forward transport. 14-3-3 binding overcomes retention in endoplasmic reticulum by dibasic signals.

Authors:  Ita O'Kelly; Margaret H Butler; Noam Zilberberg; Steve A N Goldstein
Journal:  Cell       Date:  2002-11-15       Impact factor: 41.582

Review 7.  Genetic association and cellular function of MC1R variant alleles in human pigmentation.

Authors:  R A Sturm; D L Duffy; N F Box; R A Newton; A G Shepherd; W Chen; L H Marks; J H Leonard; N G Martin
Journal:  Ann N Y Acad Sci       Date:  2003-06       Impact factor: 5.691

Review 8.  The role of melanocortin-1 receptor polymorphism in skin cancer risk phenotypes.

Authors:  Richard A Sturm; David L Duffy; Neil F Box; Wei Chen; Darren J Smit; Darren L Brown; Jennifer L Stow; J Helen Leonard; Nicholas G Martin
Journal:  Pigment Cell Res       Date:  2003-06

9.  Rate limiting factors in melanocortin 1 receptor signalling through the cAMP pathway.

Authors:  Jesús Sánchez Más; Ineke Gerritsen; Christa Hahmann; Celia Jiménez-Cervantes; José Carlos García-Borrón
Journal:  Pigment Cell Res       Date:  2003-10

Review 10.  Quantitative analysis of eumelanin and pheomelanin in humans, mice, and other animals: a comparative review.

Authors:  Shosuke Ito; Kazumasa Wakamatsu
Journal:  Pigment Cell Res       Date:  2003-10
View more
  22 in total

1.  Modeling MC1R rare variants: a structural evaluation of variants detected in a Mediterranean case-control study.

Authors:  Maider Ibarrola-Villava; Maria Peña-Chilet; Marta J Llorca-Cardeñosa; Sara Oltra; Conrado-Martinez Cadenas; Jeronimo Bravo; Gloria Ribas
Journal:  J Invest Dermatol       Date:  2013-11-11       Impact factor: 8.551

2.  Rab26 modulates the cell surface transport of α2-adrenergic receptors from the Golgi.

Authors:  Chunman Li; Yi Fan; Tien-Hung Lan; Nevin A Lambert; Guangyu Wu
Journal:  J Biol Chem       Date:  2012-10-26       Impact factor: 5.157

3.  Mechanisms of melanocortin-2 receptor (MC2R) internalization and recycling in human embryonic kidney (hek) cells: identification of Key Ser/Thr (S/T) amino acids.

Authors:  Simon Roy; Sébastien Jean Roy; Sandra Pinard; Louis-Daniel Taillefer; Mohamed Rached; Jean-Luc Parent; Nicole Gallo-Payet
Journal:  Mol Endocrinol       Date:  2011-09-15

4.  A naturally occurring GIP receptor variant undergoes enhanced agonist-induced desensitization, which impairs GIP control of adipose insulin sensitivity.

Authors:  Sameer Mohammad; Rajesh T Patel; Joanne Bruno; Muhammad Siyab Panhwar; Jennifer Wen; Timothy E McGraw
Journal:  Mol Cell Biol       Date:  2014-07-21       Impact factor: 4.272

5.  How Genes Modulate Patterns of Aging-Related Changes on the Way to 100: Biodemographic Models and Methods in Genetic Analyses of Longitudinal Data.

Authors:  Anatoliy I Yashin; Konstantin G Arbeev; Deqing Wu; Liubov Arbeeva; Alexander Kulminski; Irina Kulminskaya; Igor Akushevich; Svetlana V Ukraintseva
Journal:  N Am Actuar J       Date:  2016-06-22

6.  Gain of glycosylation: a new pathomechanism of myelin protein zero mutations.

Authors:  Valeria Prada; Mario Passalacqua; Maria Bono; Paola Luzzi; Sara Scazzola; Lucilla Alessandra Nobbio; Simona Capponi; Emilia Bellone; Paola Mandich; Gianluigi Mancardi; Michael Shy; Angelo Schenone; Marina Grandis
Journal:  Ann Neurol       Date:  2012-03       Impact factor: 10.422

7.  Signaling from the human melanocortin 1 receptor to ERK1 and ERK2 mitogen-activated protein kinases involves transactivation of cKIT.

Authors:  Cecilia Herraiz; Fabrice Journé; Zalfa Abdel-Malek; Ghanem Ghanem; Celia Jiménez-Cervantes; José C García-Borrón
Journal:  Mol Endocrinol       Date:  2010-11-17

8.  Identification and functional characterization of natural human melanocortin 1 receptor mutant alleles in Pakistani population.

Authors:  Mohsin Shahzad; Julia Sires Campos; Nabeela Tariq; Cecilia Herraiz Serrano; Rizwan Yousaf; Celia Jiménez-Cervantes; Sairah Yousaf; Yar M Waryah; Haseeb A Dad; Elizabeth M Blue; Nara Sobreira; Francesc López-Giráldez; Tasleem Kausar; Muhammad Ali; Ali M Waryah; Saima Riazuddin; Rehan S Shaikh; José C García-Borrón; Zubair M Ahmed
Journal:  Pigment Cell Melanoma Res       Date:  2015-09-22       Impact factor: 4.693

9.  Reciprocal responses of fibroblasts and melanocytes to α-MSH depending on MC1R polymorphisms.

Authors:  Hedwig Stanisz; Markus Seifert; Wolfgang Tilgen; Thomas Vogt; Knuth Rass
Journal:  Dermatoendocrinol       Date:  2011-10-01

Review 10.  MC1R, the cAMP pathway, and the response to solar UV: extending the horizon beyond pigmentation.

Authors:  Jose C García-Borrón; Zalfa Abdel-Malek; Celia Jiménez-Cervantes
Journal:  Pigment Cell Melanoma Res       Date:  2014-05-30       Impact factor: 4.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.